NCT06057051View on ClinicalTrials.gov

Glaukos® iStent Infinite Trabecular Micro-Bypass System in Subjects With Mild to Moderate Primary Open-angle Glaucoma

NARecruitingINTERVENTIONAL
Enrollment

245

Participants

Timeline

Start Date

September 1, 2023

Primary Completion Date

August 31, 2025

Study Completion Date

August 31, 2027

Conditions
Glaucoma
Interventions
DEVICE

iStent Infinite

iStent Infinite Trabecular Micro-Bypass System

Trial Locations (1)

45242

RECRUITING

Glaukos Investigator Site, Cincinnati

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY